Chia Yueh Pan
Chief Executive Officer at SUNWAY BIOTECH CO., LTD.
Network origin in Chia Yueh Pan first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Chia Yueh Pan via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ASIA CEMENT CORPORATION | Construction Materials | Director/Board Member | |
StemCyte, Inc.
 StemCyte, Inc. BiotechnologyHealth Technology StemCyte, Inc. operates as a biotechnology company that collects, banks and distributes cord blood stem cell transfusion units. It focuses on stem cell transplantation, therapy, applications, diagnostics, and genomic research. The firm uses insulated containers to keep your baby's cord blood cool throughout transport. The company was founded by Denis Rodgerson and Robert Chow in 1997 and is headquartered in Covina, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Epitomics, Inc.
 Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Epitomics, Inc. an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb®) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The firm is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. | Pharmaceuticals: Major | Chairman | |
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| APPLIED BIOCODE CORPORATION | Medical Specialties | Chairman | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member | |
| Stanford University | College/University | Graduate Degree | |
| SINOPAC FINANCIAL HOLDINGS COMPANY LIMITED | Regional Banks | Director/Board Member | |
| CHINA AIRLINES, LTD. | Airlines | Director/Board Member | |
| CHUNG HWA PULP CORPORATION | Pulp & Paper | Director/Board Member | |
| VANGUARD INTERNATIONAL SEMICONDUCTOR CORPORATION | Semiconductors | Director/Board Member | |
| MIRLE AUTOMATION CORPORATION | Computer Peripherals | Director/Board Member | |
| University of British Columbia | College/University | Undergraduate Degree | |
| Santa Clara University | College/University | Masters Business Admin | |
| State University of New York at Buffalo | College/University | Doctorate Degree | |
| University of Illinois | College/University | Graduate Degree | |
| MOTECH INDUSTRIES INC. | Semiconductors | Director/Board Member | |
| National Taiwan University | College/University | Undergraduate Degree Doctorate Degree Masters Business Admin | |
| National Chengchi University | College/University | Graduate Degree | |
| National Cheng Kung University | College/University | Undergraduate Degree | |
Deloitte & Touche
 Deloitte & Touche Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche provides audit, enterprise risk management, and financial advisory services. The company delivers services in four professional areas: audit, tax, consulting, and financial advisory services. It provides its clients with global services such as entering foreign markets, raising funds, and investing in Mainland China. The company was founded in June, 2003 and is headquartered in Taipei, Taiwan. | Miscellaneous Commercial Services | Chairman | |
| TAIWAN HIGH SPEED RAIL CORPORATION | Other Transportation | Director/Board Member | |
Cardiva Medical, Inc.
 Cardiva Medical, Inc. Medical SpecialtiesHealth Technology Cardiva Medical, Inc. designs and develops vascular access management products. It offers VASCADE, an extravascular closure device designed to increase the comfort and safety of vascular closure for patients; and Catalyst, a device that supports the body's natural healing process by enhancing the vessel's inherent natural elastic recoil, tissue apposition and coagulation. The company was founded by Zia Yassinzadeh and Augustine Y. Lien in July 2002 and is headquartered in Santa Clara, CA. | Medical Specialties | Director/Board Member | |
Amkey Ventures LLC
 Amkey Ventures LLC Investment ManagersFinance Amkey Ventures LLC (Amkey Ventures) is a venture capital firm founded in 2001 by George J. Lee and Woody Sing-Wood Yeh. The firm headquartered in Fremont, California. | Investment Managers | Founder | |
Bank SinoPac Co., Ltd.
 Bank SinoPac Co., Ltd. Regional BanksFinance Bank SinoPac Co. Ltd. provides commercial banking services. The firm's services include deposits, personal banking, electronic financial transactions, short term and long term credits. The company is located in Taipei, Taiwan. | Regional Banks | Director/Board Member | |
Biokey, Inc.
 Biokey, Inc. Pharmaceuticals: GenericHealth Technology Biokey, Inc. develops and markets generic drugs. Its services include regulatory support, analytical services, product development, and GMP manufacturing. The company was founded by George J. Lee in 2001 and is headquartered in Fremont, CA. | Pharmaceuticals: Generic | Founder | |
GenePharm, Inc.
 GenePharm, Inc. Pharmaceuticals: MajorHealth Technology GenePharm, Inc. develops and commercializes therapeutics for skin related problems. Its services include formulation development, pre-clinical research, brand creation. technology licensing, technology alliance, and technology transfer. The company was founded in March 6, 2000 and is headquartered in the Sunnyvale, CA. | Pharmaceuticals: Major | Founder | |
| University of Yuan Ze | College/University | Director/Board Member | |
Protech Pharmaservices Corp.
 Protech Pharmaservices Corp. Medical/Nursing ServicesHealth Services Protech Pharmaservices Corp. engages in the provision of clinical research and contract laboratory services, as well as sale of scientific instruments. Its services include bio analytical services, central laboratory services, early-phase clinical services, and late-phase clinical services. The company was founded on February 24, 1997 and is headquartered in Taipei, Taiwan. | Medical/Nursing Services | Director/Board Member | |
| Meijo University | College/University | Graduate Degree | |
| Eli C. Wang & Co. CPAs | Corporate Officer/Principal | ||
| E INK HOLDINGS INC. | Computer Peripherals | Director/Board Member | |
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Director/Board Member | |
| T N Soong & Co. | Chairman | ||
| T N Soong Foundation | Director/Board Member | ||
| Sung Tso Nan Memorial Foundation | Director/Board Member | ||
| Shanghai Commercial & Savings Bank Cultural & Educational Fdn | Miscellaneous Commercial Services | Director/Board Member | |
| Pharmout Laboratories, Inc. | Founder | ||
| Eureka Bioventure Partners LLC | Founder | ||
| Pharmdel, Inc. | Founder | ||
| PharmTak, Inc. | Director/Board Member | ||
| FORESEE PHARMACEUTICALS CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
RevMAb Biosciences, Inc.
 RevMAb Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services RevMAb Biosciences, Inc. operates as a biotechnology company. It focuses on the development of monoclonal antibodies using a revolutionary technology that does not require cell fusion and hybridoma generation. The company is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Chairman | |
GenePharm Biotech Corp.
 GenePharm Biotech Corp. Pharmaceuticals: MajorHealth Technology Part of Munir Sukhtian Pharmaceuticals, GenePharm Biotech Corp. develops and commercializes preventive and curative therapeutics for skin-related problems. The company is based in Xizhi District, Taiwan. | Pharmaceuticals: Major | Chairman | |
| Aulisa Medical Technologies, Inc. | Director/Board Member | ||
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| Taiwan | 27 |
| United States | 23 |
| Canada | 2 |
| Japan | 2 |
Sectoral
| Health Technology | 15 |
| Consumer Services | 11 |
| Electronic Technology | 6 |
| Commercial Services | 5 |
| Finance | 4 |
Operational
| Director/Board Member | 33 |
| Chairman | 10 |
| Founder | 6 |
| Corporate Officer/Principal | 6 |
| Independent Dir/Board Member | 5 |
Most connected contacts
| Insiders | |
|---|---|
| George Lee | 26 |
| Ching Yi Wang | 24 |
| Hsu Chih Hsu | 4 |
| Yan Lien | 4 |
| Tzu Ming Pan | 2 |
| Yuan Chang Cheng | 2 |
| Teng Hsien Tseng | 2 |
- Stock Market
- Insiders
- Chia Yueh Pan
- Company connections
